These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19156622)

  • 21. Serum soluble receptor for advanced glycation end products correlates inversely with measures of adiposity in young adults.
    Davis KE; Prasad C; Vijayagopal P; Juma S; Imrhan V
    Nutr Res; 2014 Jun; 34(6):478-85. PubMed ID: 25026914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular disease: what's all the AGE/RAGE about?
    Barlovic DP; Thomas MC; Jandeleit-Dahm K
    Cardiovasc Hematol Disord Drug Targets; 2010 Mar; 10(1):7-15. PubMed ID: 20041839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications.
    Yan SF; Ramasamy R; Schmidt AM
    Nat Clin Pract Endocrinol Metab; 2008 May; 4(5):285-93. PubMed ID: 18332897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RAGE biology, atherosclerosis and diabetes.
    Barlovic DP; Soro-Paavonen A; Jandeleit-Dahm KA
    Clin Sci (Lond); 2011 Jul; 121(2):43-55. PubMed ID: 21457145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RAGE and its ligands: a lasting memory in diabetic complications?
    Yan SF; Ramasamy R; Bucciarelli LG; Wendt T; Lee LK; Hudson BI; Stern DM; Lalla E; DU Yan S; Rong LL; Naka Y; Schmidt AM
    Diab Vasc Dis Res; 2004 May; 1(1):10-20. PubMed ID: 16305050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The interplay between hyperglycemia-induced oxidative stress markers and the level of soluble receptor for advanced glycation end products (sRAGE) in K562 cells.
    Shemirani F; Yazdanparast R
    Mol Cell Endocrinol; 2014 Aug; 393(1-2):179-86. PubMed ID: 24911882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble form of a receptor for advanced glycation end products (sRAGE) as a biomarker.
    Yamagishi S; Matsui T
    Front Biosci (Elite Ed); 2010 Jun; 2(4):1184-95. PubMed ID: 20515790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of advanced glycation end product (AGE)-receptor (RAGE) system by PPAR-gamma agonists and its implication in cardiovascular disease.
    Yamagishi S; Nakamura K; Matsui T
    Pharmacol Res; 2009 Sep; 60(3):174-8. PubMed ID: 19646657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular signalling of the receptor for advanced glycation end products (RAGE).
    Xie J; Méndez JD; Méndez-Valenzuela V; Aguilar-Hernández MM
    Cell Signal; 2013 Nov; 25(11):2185-97. PubMed ID: 23838007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes.
    Yamagishi S
    Exp Gerontol; 2011 Apr; 46(4):217-24. PubMed ID: 21111800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury.
    Soulis T; Thallas V; Youssef S; Gilbert RE; McWilliam BG; Murray-McIntosh RP; Cooper ME
    Diabetologia; 1997 Jun; 40(6):619-28. PubMed ID: 9222639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond.
    Yan SF; Ramasamy R; Naka Y; Schmidt AM
    Circ Res; 2003 Dec; 93(12):1159-69. PubMed ID: 14670831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous secretory receptor for advanced glycation end-products and cardiovascular disease in end-stage renal disease.
    Nishizawa Y; Koyama H
    J Ren Nutr; 2008 Jan; 18(1):76-82. PubMed ID: 18089449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease.
    Yamagishi S; Nakamura K; Inoue H; Kikuchi S; Takeuchi M
    Med Hypotheses; 2005; 64(6):1205-7. PubMed ID: 15823718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model.
    Wang K; Zhou Z; Zhang M; Fan L; Forudi F; Zhou X; Qu W; Lincoff AM; Schmidt AM; Topol EJ; Penn MS
    J Pharmacol Exp Ther; 2006 Apr; 317(1):37-43. PubMed ID: 16368901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for a role of advanced glycation end products in atrial fibrillation.
    Raposeiras-Roubín S; Rodiño-Janeiro BK; Grigorian-Shamagian L; Seoane-Blanco A; Moure-González M; Varela-Román A; Álvarez E; González-Juanatey JR
    Int J Cardiol; 2012 Jun; 157(3):397-402. PubMed ID: 21652096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic Interventions for Advanced Glycation-End Products and its Receptor- Mediated Cardiovascular Disease.
    Prasad K; Tiwari S
    Curr Pharm Des; 2017; 23(6):937-943. PubMed ID: 27719648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury.
    Yonekura H; Yamamoto Y; Sakurai S; Petrova RG; Abedin MJ; Li H; Yasui K; Takeuchi M; Makita Z; Takasawa S; Okamoto H; Watanabe T; Yamamoto H
    Biochem J; 2003 Mar; 370(Pt 3):1097-109. PubMed ID: 12495433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble forms of RAGE in human diseases: clinical and therapeutical implications.
    Santilli F; Vazzana N; Bucciarelli LG; Davì G
    Curr Med Chem; 2009; 16(8):940-52. PubMed ID: 19275604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Receptor of advanced glycation endproducts RAGE/AGER: an integrative view for clinical applications].
    Barbezier N; Tessier FJ; Chango A
    Ann Biol Clin (Paris); 2014; 72(6):669-80. PubMed ID: 25486663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.